Earnings History Data for Veracyte, Inc. (VCYT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Veracyte, Inc.

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
06-11-2024 AH VCYT Veracyte, Inc. 2,690 0.19 0.02 -0.03 Veracyte Non-GAAP EPS of $0.33 beats by $0.16, revenue of $115.86M beats by $6.03M
[11/6/2024 4:40 PM]		 37.30 0.71 
(1.95%)		 39.49 2.90 
(7.93%)		 18.61 - 41.43 1,695,114 670,000 5,894
06-08-2024 AH VCYT Veracyte, Inc. 1,750 0.30 -0.03 -0.12 Veracyte beats top-line and bottom-line estimates; raises FY24 outlook
[8/6/2024 5:25 PM]		 26.99 5.17 
(23.68%)		 26.00 4.18 
(19.16%)		 18.61 - 30.86 3,951,341 860,000 11,992
07-05-2024 AH VCYT Veracyte 1,543 -0.02 -0.19 0.00 Veracyte GAAP EPS of -$0.02 beats by $0.13, revenue of $96.84M beats by $3.48M
[5/7/2024 4:17 PM]		 20.09 -0.94 
(-4.47%)		 21.76 0.73 
(3.47%)		 18.61 - 30.52 770,033 620,000 682
22-02-2024 AH VCYT Veracyte, Inc. 1,810 -0.04 -0.07 -0.05 Veracyte GAAP EPS of -$0.39 misses by $0.30, revenue of $98.2M beats by $5.42M
[2/22/2024 4:32 PM]		 22.17 -2.17 
(-8.92%)		 23.05 -1.29 
(-5.30%)		 19.52 - 30.52 706,327 640,000 143,821
07-11-2023 AH VCYT Veracyte, Inc. 1,780 -0.03 -0.16 -0.12 Veracyte GAAP EPS of -$0.41 misses by $0.26, revenue of $90.1M beats by $5.71M
[11/7/2023 4:23 PM]		 23.15 -0.86 
(-3.58%)		 25.23 1.22 
(5.08%)		 19.52 - 32.40 851,725 710,000 1,086
08-08-2023 AH VCYT Veracyte, Inc. 1,850 -0.12 -0.16 -0.13 Veracyte GAAP EPS of -$0.12 beats by $0.04, revenue of $90.32M beats by $7.23M
[8/8/2023 4:43 PM]		 26.71 1.71 
(6.84%)		 26.25 1.25 
(5.00%)		 14.92 - 32.40 773,115 600,000 1,118
04-05-2023 AH 4:05 PM ET
(May 4)		 VCYT Veracyte, Inc. 1,510 -0.11 -0.14 -0.20 Veracyte GAAP EPS of -$0.11 beats by $0.03, revenue of $82.42M beats by $6.67M
[5/4/2023 4:46 PM]		 23.30 1.04 
(4.68%)		 22.26 0.0 
(0.00%)		 14.85 - 32.40 569,345 670,000 34,996
22-02-2023 AH 4:05 PM ET
(Feb 22)		 VCYT Veracyte, Inc. 1,820 -0.05 -0.15 -0.15 Veracyte Q4 results beat estimates, co sees FY 2023 revenue guidance in-line
[2/22/2023 4:36 PM]		 23.90 0.0 
(0.00%)		 23.95 0.05 
(0.21%)		 14.85 - 32.40 880,392 780,000 1,112
02-11-2022 AH 4:05 PM ET
(Nov 2)		 VCYT Veracyte, Inc. 1,440 -0.12 -0.24 -0.13 Veracyte GAAP EPS of -$0.12, revenue of $75.6M; raises FY outlook
[11/2/2022 4:30 PM]		 24.20 4.70 
(24.08%)		 22.65 3.15 
(16.15%)		 14.85 - 54.13 2,391,086 920,000 1,978
02-08-2022 AH 4:05 PM ET
(Aug 2)		 VCYT Veracyte, Inc. 1,750 -0.13 -0.21 -0.13 Veracyte GAAP EPS of -$0.13 beats by $0.10, revenue of $72.86M beats by $4.78M
[8/2/2022 4:18 PM]		 25.00 -1.64 
(-6.16%)		 27.00 0.36 
(1.35%)		 14.85 - 54.13 740,627 870,000 250
03-05-2022 AH 4:05 PM ET
(May 3)		 VCYT Veracyte 1,525 -0.20 -0.23 0.00 Veracyte GAAP EPS of -$0.20 beats by $0.05, revenue of $67.78M beats by $5.86M
[5/3/2022 4:15 PM]		 22.41 0.95 
(4.43%)		 21.46 0.0 
(0.00%)		 20.04 - 54.13 1,899,622 1,060,000 24,288
28-02-2022 AH 4:05 PM ET
(Feb 28)		 VCYT Veracyte, Inc. 1,860 -0.15 -0.14 -0.14 Veracyte GAAP EPS of -$0.15 beats by $0.04, revenue of $67.3M beats by $4.57M
[2/28/2022 4:14 PM]		 27.93 0.13 
(0.47%)		 27.80 0.0 
(0.00%)		 22.00 - 64.83 1,029,254 740,000 13,110
09-11-2021 AH 4:05 PM ET
(Nov 9)		 VCYT Veracyte, Inc. 3,720 -0.13 -0.14 -0.08 Veracyte EPS misses by $0.03, beats on revenue
[11/9/2021 4:26 PM]		 46.05 -4.04 
(-8.07%)		 50.09 0.0 
(0.00%)		 32.87 - 86.03 675,735 500,000 5,330
29-07-2021 AH 4:05 PM ET
(Jul 29)		 VCYT Veracyte, Inc. 2,640 -0.13 -0.25 -0.22 Veracyte EPS beats by $0.13, beats on revenue
[7/29/2021 4:13 PM]		 44.54 5.31 
(13.54%)		 41.00 1.77 
(4.51%)		 28.82 - 86.03 1,133,964 560,000 9,191
10-05-2021 AH 4:05 PM ET
(May 10)		 VCYT Veracyte, Inc. 3,090 -0.11 -0.12 -0.24 Veracyte EPS misses by $0.55, beats on revenue
[5/10/2021 4:13 PM]		 39.91 -2.40 
(-5.67%)		 39.51 -2.80 
(-6.62%)		 22.69 - 86.03 1,707,978 660,000 2,020
17-02-2021 AH 4:05 PM ET
(Feb 17)		 VCYT Veracyte, Inc. 5,030 -0.14 -0.09 -0.15 Veracyte EPS misses by $0.02, beats on revenue
[2/17/2021 4:30 PM]		 69.82 -4.18 
(-5.65%)		 74.00 0.0 
(0.00%)		 13.90 - 86.03 1,011,323 1,463,798 17,134
02-11-2020 AH 4:05 PM ET
(Nov 2)		 VCYT Veracyte, Inc. 2,120 -0.08 -0.18 -0.02 Veracyte EPS beats by $0.12, beats on revenue
[11/2/2020 4:33 PM]		 38.40 3.40 
(9.71%)		 34.03 -0.97 
(-2.77%)		 13.90 - 44.64 677,078 491,517 13,766
30-07-2020 AH 4:05 PM ET
(Jul 30)		 VCYT Veracyte, Inc. 1,420 -0.22 -0.22 -0.05 Veracyte EPS beats by $0.05, beats on revenue
[7/30/2020 4:15 PM]		 36.04 2.83 
(8.52%)		 33.40 0.19 
(0.57%)		 13.90 - 36.20 649,923 501,300 19,893
06-05-2020 AH VCYT Veracyte, Inc. 1,370 -0.24 -0.18 -0.05 0.0 0.0 
(0.00%)		 0.0 0.0 
(0.00%)		 0.0 - 0.0 0 0 0